New mouse model for dengue virus vaccine testing

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 783-786

  Johnson, Alison J ^a,b   Roehrig, John T ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DENGUE; DENGUE VIRUS; DRUG EFFICACY; IMMUNOGENICITY; INFECTION PREVENTION; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VACCINE PRODUCTION;

EID: 0032889018     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.783-786.1999     Document Type: Article

References (14)

1. Chaturvedi, U. C., R. Dhawan, M. Khanna, and A. Mathur. 1991. Breakdown of the blood brain barrier during dengue virus infection of mice. J. Gen. Virol. 72:859-866.
2. Cole, G. A., and C. L. Wisseman, Jr. 1969. Pathogenesis of type 1 dengue virus infection in suckling, weanling and adult mice. 1. The relation of virus replication to interferon and antibody formation. Am. J. Epidemiol. 89:669-680.
3. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178:2243-2247.
4. Deubel, V., R. M. Kinney, J. J. Esposito, C. B. Cropp, A. V. Vorndam, T. P. Monath, and D. W. Trent. 1988. Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue. J. Gen. Virol. 69:1921-1929.
5. Falgout, B., M. Bray, J. J. Schlesinger, and C.-J. Lai. 1990. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J. Virol. 64:4356-4363.
6. Fiette, L., C. Aubert, U. Müller, S. Huang, M. Aguet, M. Brahic, and J.-F. Bureau. 1995. Theiler's virus infection of 129Sv mice that lack the interferon α/β or interferon γ receptors. J. Exp. Med. 181:2069-2076.
7. Graham, M. B., D. K. Dalton, D. Giltinan, V. L. Braciale, T. A. Stewart, and T. J. Braciale. 1993. Response to influenza infection in mice with a targeted disruption in the interferon γ gene. J. Exp. Med. 178:1725-1732.
8. Gubler, D. J., and G. G. Clark. 1995. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg. Infect. Dis. 1:55-57.
9. Hotta, H., I. Murakami, K. Miyasaki, Y. Takeda, H. Shirane, and S. Hotta. 1981. Inoculation of dengue virus into nude mice. J. Gen. Virol. 52:71-76.
10. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilček, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259:1742-1745.
11. Hunt, A. R., W. A. Short, A. J. Johnson, R. A. Bolin, and J. T. Roehrig. 1991. Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication. Virology 185:281-290.
12. Kaufman, B. M., P. L. Summers, D. R. Dubois, and K. H. Eckels. 1987. Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am. J. Trop. Med. Hyg. 36:427-434.
13. Kinney, R. M., S. Butrapet, G.-J. J. Chang, K. R. Tsuchiya, J.T. Roehrig, N. Bhamarapravati, and D. J. Gubler. 1997. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230:300-308.
14. Kurane, I., A. Meager, and F. A. Ennis. 1986. Induction of interferon alpha and gamma from human lymphocytes by dengue virus-infected cells. J. Gen. Virol. 67:1653-1661.